- Home
- INHD vs PMN Comparison
INHD vs PMN Comparison
Compare INHD & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INHD
- PMN
- Stock Information
- Founded
- INHD 2019
- PMN 2004
- Country
- INHD United States
- PMN Canada
- Employees
- INHD N/A
- PMN N/A
- Industry
- INHD
- PMN Pharmaceuticals and Biotechnology
- Sector
- INHD
- PMN Health Care
- Exchange
- INHD Nasdaq
- PMN Nasdaq
- Market Cap
- INHD 19.8M
- PMN 18.8M
- IPO Year
- INHD 2023
- PMN N/A
- Fundamental
- Price
- INHD $1.90
- PMN $0.51
- Analyst Decision
- INHD
- PMN Strong Buy
- Analyst Count
- INHD 0
- PMN 2
- Target Price
- INHD N/A
- PMN $4.50
- AVG Volume (30 Days)
- INHD 2.4M
- PMN 55.0K
- Earning Date
- INHD 05-02-2025
- PMN 05-12-2025
- Dividend Yield
- INHD N/A
- PMN N/A
- EPS Growth
- INHD N/A
- PMN N/A
- EPS
- INHD N/A
- PMN N/A
- Revenue
- INHD $1,559,595.00
- PMN N/A
- Revenue This Year
- INHD N/A
- PMN N/A
- Revenue Next Year
- INHD N/A
- PMN N/A
- P/E Ratio
- INHD N/A
- PMN N/A
- Revenue Growth
- INHD 287.83
- PMN N/A
- 52 Week Low
- INHD $2.21
- PMN $0.51
- 52 Week High
- INHD $19.78
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- INHD 30.31
- PMN 37.42
- Support Level
- INHD $2.21
- PMN $0.48
- Resistance Level
- INHD $19.78
- PMN $0.59
- Average True Range (ATR)
- INHD 2.23
- PMN 0.07
- MACD
- INHD -0.62
- PMN -0.01
- Stochastic Oscillator
- INHD 3.27
- PMN 14.00
About INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.